Implantable Defibrillators Market By Product Type (Transvenous Implantable Cardioverter-Defibrillator (T-ICDs), Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS), Cardiac Resynchronization Therapy Defibrillator (CRT-D)) - Global Industry Analysis & Forecast to 2025

Industry Outlook and Trend Analysis

The Implantable Defibrillators Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Implantable defibrillators are utilized to counteract sudden death in patients who have atrial fibrillation or ventricular tachycardia. These devices are embedded inside the patient’s body and can perform defibrillation, pacing of the heart, and cardioversion. The heart rhythms that are irregular and that require ICD embed incorporate bradycardia, ventricular tachycardia, and ventricular fibrillation.

Drivers and Restraints

Increasing geriatric populace; increment in predominance of chronic wellbeing conditions, for example, ventricular fibrillation, cardiac arrhythmia, and pulseless ventricular tachycardia, development in inclination for S-ICDs, and ascend in awareness among patients about implantable defibrillators are anticipated to drive the market development. Nonetheless, absence of awareness towards the accessibility of implantable defibrillator to avert sudden heart failure (SCA) and selection of these devices in low-and center wage economies are anticipated to hamper the market development.

Regional Insights

North America dominated the worldwide market in 2015, and is anticipated to keep up its strength amid the figure time frame. This is ascribed to the ascent in frequency of sudden heart failure (SCA), increment in selection of S-ICDs, high acquiring force, and accessibility of cutting edge healthcare centers.

By Region

North America



Rest of Europe


South Korea
Southeast Asia
Rest of Asia-Pacific

South America

Rest of South America

Middle East and Africa

Saudi Arabia
South Africa
Rest of MEA

Competitive Analysis

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

LivaNova PLC Company
MicroPort Scientific Corporation
Medtronic plc
St. Jude Medical, Inc
Sorin Group
Boston Scientific Corporation
Imricor Medical Systems
Mayo Clinic US
MRI Interventions, Inc
Biotronik Se & Co.KG

Some of the key questions answered by the report are:

What was the market size in 2014 and forecast from 2015 to 2025?
What will be the industry market growth from 2015 to 2025?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?